Want to see HK:0348 full AI Analyst Report?
Total Valuation
China Healthwise Holdings has a market cap or net worth of HK$70.88M. The enterprise value is HK$154.73M.
Market CapHK$70.88M
Enterprise ValueHK$154.73M
Share Statistics
China Healthwise Holdings has 770,480,830 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding770,480,830
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
China Healthwise Holdings’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is -14.74%.
Return on Equity (ROE)0.07
Return on Assets (ROA)-0.02
Return on Invested Capital (ROIC)-14.74%
Return on Capital Employed (ROCE)0.69
Revenue Per Employee1.31M
Profits Per Employee-34.29K
Employee Count76
Asset Turnover0.80
Inventory Turnover1.55
Valuation Ratios
The current PE Ratio of China Healthwise Holdings is ―. China Healthwise Holdings’s PEG ratio is 0.43.
PE Ratio―
PS Ratio1.05
PB Ratio-2.72
Price to Fair Value-2.72
Price to FCF35.56
Price to Operating Cash Flow21.80
PEG Ratio0.43
Income Statement
In the last 12 months, China Healthwise Holdings had revenue of 99.56M and earned -2.61M in profits. Earnings per share was >-0.01.
Revenue99.56M
Gross Profit37.20M
Operating Income-12.67M
Pretax Income-3.29M
Net Income-2.61M
EBITDA-12.34M
Earnings Per Share (EPS)>-0.01
Cash Flow
In the last 12 months, operating cash flow was 3.04M and capital expenditures -3.47M, giving a free cash flow of -431.00K billion.
Operating Cash Flow3.04M
Free Cash Flow-431.00K
Free Cash Flow per Share>-0.01
Dividends & Yields
China Healthwise Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.73
52-Week Price Change-36.30%
50-Day Moving Average0.07
200-Day Moving Average0.11
Relative Strength Index (RSI)60.27
Average Volume (3m)735.98K
Important Dates
China Healthwise Holdings upcoming earnings date is Aug 20, 2026, TBA (Confirmed).
Last Earnings DateMar 27, 2026
Next Earnings DateAug 20, 2026
Ex-Dividend Date―
Financial Position
China Healthwise Holdings as a current ratio of 0.83, with Debt / Equity ratio of -275.72%
Current Ratio0.83
Quick Ratio0.55
Debt to Market Cap0.94
Net Debt to EBITDA-7.86
Interest Coverage Ratio-0.92
Taxes
In the past 12 months, China Healthwise Holdings has paid 686.00K in taxes.
Income Tax686.00K
Effective Tax Rate-0.21
Enterprise Valuation
China Healthwise Holdings EV to EBITDA ratio is -16.35, with an EV/FCF ratio of 68.46.
EV to Sales2.03
EV to EBITDA-16.35
EV to Free Cash Flow68.46
EV to Operating Cash Flow66.36
Balance Sheet
China Healthwise Holdings has HK$62.62M in cash and marketable securities with HK$106.13M in debt, giving a net cash position of -HK$43.51M billion.
Cash & Marketable SecuritiesHK$62.62M
Total DebtHK$106.13M
Net Cash-HK$43.51M
Net Cash Per Share-HK$0.06
Tangible Book Value Per Share-HK$0.03
Margins
Gross margin is 37.36%, with operating margin of -12.72%, and net profit margin of -2.62%.
Gross Margin37.36%
Operating Margin-12.72%
Pretax Margin-3.31%
Net Profit Margin-2.62%
EBITDA Margin-12.39%
EBIT Margin-12.72%
Analyst Forecast
The average price target for China Healthwise Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-12.34%
EPS Growth Forecast93.50%